Balyasny Asset Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-310,359
| Closed | -$2.58M | – | 2351 |
|
|
2023
Q3 | $2.58M | Hold |
310,359
| – | – | 0.01% | 943 |
|
|
2023
Q2 | $3.21M | Sell |
310,359
-389,641
| -56% | -$4.02M | 0.01% | 893 |
|
|
2023
Q1 | $7.09M | Hold |
700,000
| – | – | 0.02% | 704 |
|
|
2022
Q4 | $6.97M | Buy |
700,000
+300,000
| +75% | +$2.99M | 0.02% | 669 |
|
|
2022
Q3 | $3.9M | Hold |
400,000
| – | – | 0.01% | 869 |
|
|
2022
Q2 | $3.88M | Hold |
400,000
| – | – | 0.01% | 855 |
|
|
2022
Q1 | $3.88M | Hold |
400,000
| – | – | 0.01% | 826 |
|
|
2021
Q4 | $3.88M | Hold |
400,000
| – | – | 0.01% | 790 |
|
|
2021
Q3 | $3.88M | Buy |
+400,000
| New | +$3.88M | 0.02% | 755 |
|